Fidelma Cahill
Overview
Explore the profile of Fidelma Cahill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheill G, Brady L, Hayes B, Baird A, Guinan E, Vishwakarma R, et al.
Support Care Cancer
. 2023 Apr;
31(5):292.
PMID: 37086362
Purpose: All patients living with cancer, including those with metastatic cancer, are encouraged to be physically active. This paper examines the secondary endpoints of an aerobic exercise intervention for men...
2.
Manuelli V, Cahill F, Wylie H, Gillett C, Correa I, Heck S, et al.
BMC Cancer
. 2022 Apr;
22(1):386.
PMID: 35397545
Background: Invadopodia, actin-rich structures that release metallo-proteases at the interface with extra-cellular matrix, in a punctate manner are thought to be important drivers of tumour invasion. Invadopodia formation has been...
3.
George G, Rudman S, Fleure L, Moon Z, Garmo H, Cahill F, et al.
Semin Oncol Nurs
. 2021 Dec;
38(4):151236.
PMID: 34920915
Objectives: Side effects from the prolonged use of gonadotropin-releasing hormone (GnRH) agonists may lead to nonadherence to the treatment in men with advanced prostate cancer (PCa). We investigated the reasons...
4.
Hayes B, Brady L, Sheill G, Baird A, Guinan E, Stanfill B, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572916
Interactions between circulating tumour cells (CTCs) and platelets are thought to inhibit natural killer(NK)-cell-induced lysis. We attempted to correlate CTC numbers in men with advanced prostate cancer with platelet counts...
5.
Russell B, Moss C, Shah V, Ko T, Palmer K, Sylva R, et al.
Br J Cancer
. 2021 Aug;
125(7):939-947.
PMID: 34400804
Background: Using an updated dataset with more patients and extended follow-up, we further established cancer patient characteristics associated with COVID-19 death. Methods: Data on all cancer patients with a positive...
6.
Bessa A, Bosco C, Cahill F, Russell B, Fox L, Moss C, et al.
Inquiry
. 2021 Jul;
58:469580211030217.
PMID: 34271831
Bladder cancer (BC) is the 10 most common malignancy worldwide and the patient experience is found to be worse than that for patients diagnosed with other cancer types. We aimed...
7.
Russell B, Moss C, Palmer K, Sylva R, DSouza A, Wylie H, et al.
Cancers (Basel)
. 2021 Jun;
13(10).
PMID: 34069565
Very few studies investigating COVID-19 in cancer patients have included cancer patients as controls. We aimed to identify factors associated with the risk of testing positive for SARS CoV2 infection...
8.
Cathcart P, Ribeiro L, Moore C, Ahmed H, Leslie T, Arya M, et al.
BJU Int
. 2021 Apr;
128(4):504-510.
PMID: 33891378
Objectives: To report toxicity of treatment observed in men participating in the Robotic surgery After Focal Therapy (RAFT) clinical trial. Patients And Methods: Men were eligible for this prospective single...
9.
Bessa A, Rammant E, Enting D, Bryan R, Khan M, Malde S, et al.
PLoS One
. 2021 Jan;
16(1):e0243136.
PMID: 33507907
Objectives: There is an increased awareness of the effect of a bladder cancer diagnosis and its treatments on the mental wellbeing of patients. However, few studies have evaluated the efficacy,...
10.
Brady L, Hayes B, Sheill G, Baird A, Guinan E, Stanfill B, et al.
PLoS One
. 2020 Dec;
15(12):e0243928.
PMID: 33338056
Background: Circulating tumour cells (CTCs) represent a morphologically distinct subset of cancer cells, which aid the metastatic spread. The ExPeCT trial aimed to examine the effectiveness of a structured exercise...